Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurovascular dysfunction in the development and progression of neuroinflammatory diseases.

Frontiers in cellular neuroscienceยท2026
Same author

A novel off-liver sinusoidal progenitor cells in supporting transplantable bioliver engineering.

Biomaterials advancesยท2025
Same author

Nef mediates neuroimmune response, myelin impairment, and neuronal injury in EcoHIV-infected mice.

Life science allianceยท2024
Same author

New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis.

Stem cell research & therapyยท2024
Same author

Extracellular vesicles produced by HIV-1 Nef-expressing cells induce myelin impairment and oligodendrocyte damage in the mouse central nervous system.

Journal of neuroinflammationยท2024
Same author

DEAR model in overweight endometrial cancer patients undergoing fertility-sparing treatment: A randomized controlled trial.

Gynecologic oncologyยท2024

Related Experiment Video

Updated: Jul 11, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

Cellular approaches for stimulating CNS remyelination.

Robert H Miller1, Lianhua Bai

  • 1Center for Translational Neuroscience, Department of Neurosciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA. rhm3@case.edu

Regenerative Medicine
|October 3, 2007
PubMed
Summary
This summary is machine-generated.

Stem cells show promise for treating demyelinating diseases by promoting myelin repair and modulating immune responses. Further research is crucial to understand their full potential in conditions like multiple sclerosis.

More Related Videos

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System
06:07

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System

Published on: December 17, 2021

Related Experiment Videos

Last Updated: Jul 11, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System
06:07

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System

Published on: December 17, 2021

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Immunology

Background:

  • Myelination is essential for vertebrate nervous system function.
  • Oligodendrocyte loss and demyelination cause severe impairment.
  • Spontaneous remyelination in diseases like multiple sclerosis (MS) eventually fails, leading to disability.

Purpose of the Study:

  • To discuss stem cell applications for treating demyelinating diseases.
  • To explore strategies for promoting myelin repair, including growth factors and cell delivery.
  • To highlight the role of immune modulation in demyelination treatment.

Main Methods:

  • Review of recent studies on stem cell capacity for myelin repair and immune modulation.
  • Assessment of mesenchymal stem cells for therapeutic potential in demyelinating diseases.
  • Consideration of multi-faceted repair strategies for disorders like leukodystrophies.

Main Results:

  • Stem cells, including mesenchymal stem cells, can promote endogenous myelin repair.
  • Stem cells possess the ability to modulate immune responses relevant to demyelination.
  • Current stem cell clinical trials for demyelinating diseases are limited but expected to grow.

Conclusions:

  • Stem cell therapy is a promising avenue for treating demyelinating diseases.
  • Understanding stem cell mechanisms, applicability, and limitations is critical for therapeutic development.
  • Future research will likely expand stem cell-based clinical trials for conditions such as MS and leukodystrophies.